News of an exciting new development for Regulatory Rapporteur starting in October 2025.
This industry news update shares the MHRA’s guidance for the manufacture of personalised medicines.
This industry news update is about the ongoing projects as a part of AI Airlock led by the MHRA.
This industry news update is on SGLT-2 inhibitors that NICE are expanding access for as an alternative treatment for type 2 diabetes.
An update on how readers’ feedback is informing future developments for Regulatory Rapporteur.
This industry news update shares the EFPIA’s guidance document to help support the submission process for novel methodologies.
This industry news update discusses George Francis Tidmarsh, M.D., Ph.D., who has been appointed as Director of the Center for Drug Evaluation and Research.
InConversation talks careers with Zohra Nasir and Aksa Rahman